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Intracellular Signaling: Peripatetic
Ras
Ras proteins traffic between the plasma membrane and endomembranes and
signal from the cytosolic face of a variety of organelles. Palmitoylated N-Ras
and H-Ras signal from early endosomes. A recent study reports that K-Ras
resides on and signals from various types of endosomes, including late
endosomes/lysosomes and multivesicular bodies.
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It has been three decades since Ras
was reported to reside on the inner
leaflet of the plasma membrane. This
observation, coupled with subsequent
genetic and biochemical data that
placed Ras immediately downstream
of mitogen receptors on the cell
surface, led to the idea that Ras signals
exclusively from the plasma
membrane. The discovery that Ras
proteins are targeted to membranes
by virtue of carboxy-terminal lipid
modifications strengthened this notion.
Indeed, until ten years ago Ras
signaling was considered to be strictly
confined to the realm of the plasma
membrane. The advent of green
fluorescent protein (GFP) changed all
of that. As soon as Ras proteins were
tagged with GFP, it became evident
that a variety of subcellular
compartments were decorated with
Ras proteins [1,2], and this multiplicity
of subcellular localizations has been
verified by immunofluorescence
studies of endogenous protein [2].
Since that time, GFP-tagged Ras has
taught us much about the wanderings
of this prototypical small GTPase that
controls a wide variety of cellular
processes, including growth, survival
and differentiation.
The four mammalian Ras gene
products — H-Ras, N-Ras, K-Ras4A
and K-Ras4B — begin their lives in the
cytosol as globular hydrophilic proteins
that display a carboxy-terminal CAAX
sequence. This sequence is the signal
for a series of post-translational
modifications that include
farnesylation, AAX proteolysis and
carboxyl methylation. The enzymes
that catalyze AAX removal and
carboxyl methylation are restricted to
the endoplasmic reticulum (ER), which
serves as a way station for nascent
Ras. H-Ras, N-Ras and K-Ras4A are
further modified with one or two
palmitates. The enzyme thatpalmitoylates Ras resides on the Golgi
apparatus. In contrast to the other
isoforms, K-Ras4B is not palmitoylated
and requires no further modification
for full membrane affinity. Instead,
K-Ras4B localization depends on
a polybasic region immediately
upstream of its carboxy-terminal
farnesyl cysteine. Thus, K-Ras4B,
hereafter referred to simply as K-Ras, is
unique among the Ras isoforms and
its subcellular trafficking is distinct.
K-Ras is also the isoform most often
associated with human cancer. Cancer
biologists hope to exploit the unique
features of K-Ras trafficking to develop
new anti-Ras drugs.
As peripheral membrane proteins,
Ras proteins have two ways by which
they can move from one membrane
compartment to another. First, they can
travel like intrinsic membrane proteins
that are transferred from compartment
to compartment via vesicular transport.
Second, they can detach from the
donor membrane and move through
the aqueous phase of the cytosol,
with or without a chaperone to shield
their farnesyl chain, to the acceptor
membrane. Significant evidence
exists for each mode of transport.
GFP-tagged Ras proteins can be
readily observed on highly motile
vesicles, some of which travel along
microtubules in a linear, saltatory
fashion [2]. N-Ras and H-Ras
have been found to undergo a
palmitoylation/depalmitoylation cycle,
whereby depalmitoylation favors
release of the GTPases from the inner
leaflet of the plasma membrane from
whence they travel in a retrograde
manner, via diffusion through the
cytosol, to the Golgi apparatus. Upon
arrival at the Golgi, Ras proteins are
repalmitoylated and thereby once
again affinity-trapped in the membrane
and sent back to the plasmamembrane
by vesicular transport [3,4]. Because
K-Ras associates with the plasma
membrane via an intrinsic polybasic
sequence rather than a labile palmitateCURBIO 7242_7260modification, on first principles one
might assume that its membrane
association is constitutive. Elegant
studies by John Silvius et al. [5] showed
this is not the case; rather, plasma
membrane K-Ras is in a dynamic
equilibrium with a pool in the cytosol.
More recently, the association of
K-Ras with the inner leaflet of the
plasma membrane has been shown
to be regulated by calmodulin binding
to the polybasic region [6] and
by protein kinase C-mediated
phosphorylation of serine 181 within
the polybasic region [7].
GFP-tagged Ras proteins have been
visualized on the plasma membrane,
Golgi apparatus, ER, mitochondria and
a variety of endosomes. Ras isoforms
display different degrees of association
with endomembranes; N-RasRH-Ras
> K-Ras [2]. These observations raise
the obvious question of whether
endomembrane-associated Ras is
capable of signaling and, perhapsmore
importantly, whether the signal output
varies depending on the subcellular
platform? Fluorescent probes of Ras
activity have been used to address
this question and the answer appears
to be, yes; Ras can become activated
on endomembrane and send a signal
down various pathways and the
outcome and duration of signaling
depends, to some extent, on location
[8]. The most compelling evidence for
compartmentalized Ras signaling
comes from studies of thymocytes
that require Ras–MAPK signaling
for both of the diametrically opposed
fates — positive selection
(proliferation) and negative selection
(apoptosis). Peptides that provoke
positive selection activate Ras and
MAPK on the Golgi apparatus,
whereas those that stimulate negative
selection activate this pathway from
the plasma membrane [9].
Compartmentalized Ras signaling
is conserved back to fission yeast,
in which Ras1p regulates mating
from the plasma membrane and
cell morphology from
endomembrane [10].
Endosomes serve as the most
diverse and dynamic endomembrane
compartment upon which Ras has
been found to reside and signal.
Although endocytosis was originally
thought to limit signaling by removing
receptors from the surface, several
groups have shown that, in many
contexts, efficient growth factor
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Figure 1. K-Ras associates with endosomes.
Clathrin-dependent and -independent endocytosis internalizes growth factor receptors, such as the EGF receptor, into at least two classes of
early endosomes — those that are APPL1+/PI3P– and those that are APPL1–/PI3P+. These organelles can be interconverted by the actions of PI
3-kinase and PI 3-phosphatase. Early endosomes mature into late endosomes/lysosomes that are marked by Rab7 and LAMP1/2, and some
are further converted to multivesicular bodies (MVBs) through the action of ESCRT proteins. K-Ras has been localized to and shown to signal
from all but the APPL1+ compartment, which has not yet been examined for Ras. Because Erk signaling has been established on the APPL1+
vesicles, it is likely that this compartment also serves as a platform for K-Ras signaling. Association of K-Ras with endosome membranes may
be a consequence of scission of plasma membrane already laden with K-Ras (top left) or may be due to K-Ras release from the plasma
membrane, diffusion through the cytosol, and association with the acceptor membrane (top right). Pools of K-Ras on the inner leaflet of the
membrane and in the cytosol are in dynamic equilibrium and release from the membrane is promoted by Ca2+/calmodulin and by phosphor-
ylation of the K-Ras carboxyl terminus by protein kinase C (PKC). pErk, phosphorylated Erk.signaling requires endocytosis [11]. In
neurons, signaling endosomes have
been evoked to explain how signals
are carried over long distances along
axons [11]. Pietro De Camilli and
colleagues [12] recently reported
a major advance in endosomal
signaling when they showed that
signaling endosomes bearing the
adaptor protein APPL1 mature into
EEA1-positive early endosomes by
accumulation of phosphatidylinositol
3-phosphate (PI3P) and that this
maturation can be reverted by
hydrolysis of the 3’ phosphate.
Importantly, reversion of early
endosomes enhanced growth factorsignaling, demonstrating that the
APPL1-positive compartment is
particularly adapted for signaling.
Thus, the complexity of endosomal
signaling is greater than previously
appreciated. If one takes into account
the fact that signaling has been
observed from both clathrin-
dependent and -independent
endosomes, the complexity of the
system increases even more.
K-Ras has been observed on early
endosomes, although its signaling
properties from this location are
poorly defined. Lu et al. [13] now add
late endosomes and lysosomes to the
pantheon of membrane platformsCURBIO 7242_7260from which K-Ras signals (Figure 1).
Using high-quality imaging these
investigators report in the Journal of
Cell Biology that growth factor
signaling is not only associatedwith the
appearance of GFP–K-Ras on early,
EEA1/Rab5-bearing endosomes but
that K-Ras (but not N-Ras or H-Ras)
remains on endosomes as they
progress to late endosomes/
lysosomes, marked by Rab7 and
LAMP1/2, and multivesicular bodies
(MVBs), defined morphologically.
The authors use a Raichu–K-Ras
fluorescence resonance energy
transfer (FRET) reporter to show
that K-Ras is active on these
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evidence for Raf-1 recruitment,
association of the MAPK scaffold
protein MP1 and its adaptor p14,
and even the presence of the
phosphorylated, active form of the Erk
MAPK on the vesicles marked by GFP–
K-Ras, strongly supporting the notion
that late endosomes serve as signaling
platforms. It remains to be clarified
whether the association of K-Ras
with endosomes is a result of
clathrin-mediated endocytosis of
membranes carrying K-Ras, or whether
K-Ras arrives on these compartments
by translocation through the cytosol,
or both. Interestingly, activated Erk
was detected on the plasma
membrane before any colocalization
with K-Ras/p14-positive endosomes,
leaving open the question of whether
the entire signaling complex is
assembled on the plasma membrane
before endocytosis and then
internalizes as an intact complex, or
whether signaling complexes form
de novo on endosomes.
The most novel aspect of the work
comes from the fact that late
endosomes, lysosomes and MVBs are
shown to serve as sites for attenuating
Ras signaling. Previous studies have
implicated late endosomes and
lysosomes in downregulating
epidermal growth factor (EGF) receptor
and MAPK signaling [14], but Ras was
not examined. Lu et al. [13] show that
K-Ras is stabilized by inhibitors of
lysosomal degradation but not by
proteasome inhibitors. This latter
observation is somewhat surprising
given that K-Ras and other Ras
proteins are found in the cytosol.
Importantly, treatment of cells with
bafilomycin A and leupeptin, agents
that inhibit lysosomal proteolysis,
extended the half-life of K-Ras and
led to sustained MAPK signaling after
the cells were pulsed with EGF.
However, this phenomenon was
observed only in cells overexpressing
K-Ras, suggesting that further work
will be needed to define its
physiological role. One possibility not
considered by the authors is that K-Ras
signals from autophagosomes.
Inhibitors of lysosomal function have
been shown to promote the formation
of autophagosomes [15] and reduce
the degradation of LAMP1/2 proteins
[16] shown by Lu et al. [13] to share
a compartment with K-Ras.
The results of Lu et al. are difficult
to reconcile with those from severalgroups that reported that inhibition of
clathrin-dependent endocytosis blocks
activation and signaling of H-Ras and
N-Ras but not K-Ras [17,18]. This
isoform specificity of endosomal Ras is
concordant with the recent observation
that H-Ras and N-Ras, but not K-Ras,
are substrates for mono- and
di-ubiquitination and that this
modification stabilizes the association
of the Ras protein with endosomes [19].
Another recent finding that obfuscates
the idea of endosomes as fully
competent MAPK signaling platforms
is one in which a GFP fusion with the
MAPK kinase MEK2 was observed
both on the plasma membrane and
endosomes but the activated form of
this kinase was detected only on the
plasma membrane [20]. Moreover, the
population of endosomes decorated
with MEK2–GFP was distinct from that
which carried activated EGF receptor.
Interestingly, in this study silencing
of clathrin heavy chain augmented
EGF-mediated stimulation of Erk,
a result inconsistent with studies using
dominant-negative dynamin as a way
of blocking endocytosis [12,18,19].
Thus, it is clear that the complexity and
physiological relevance of signaling
from endosomes remains to be fully
elucidated.
A preponderance of data supports
the idea that Ras–MAPK signaling can
be sustained both from the plasma
membrane and endomembranes.
Among endomembranes, the
endosome system is the most complex
and our understanding of the diversity,
genesis, trafficking and function of
these organelles has changed
dramatically in recent years. Evidence
is mounting that Ras proteins are
among those that use endosomes of
various types as signaling platforms.
There is no doubt that the association
of Ras with endosomes adds to the
peripatetic nature of Ras. Deciphering
the biological significance of increasing
spatial complexity will require much
additional work and perhaps new
molecular tools.
References
1. Apolloni, A., Prior, I.A., Lindsay, M.,
Parton, R.G., and Hancock, J.F. (2000). H-ras
but not K-ras traffics to the plasma membrane
through the exocytic pathway. Mol. Cell. Biol.
20, 2475–2487.
2. Choy, E., Chiu, V.K., Silletti, J., Feoktistov, M.,
Morimoto, T., Michaelson, D., Ivanov, I.E., and
Philips, M.R. (1999). Endomembrane trafficking
of ras: the CAAX motif targets proteins to the
ER and Golgi. Cell 98, 69–80.
3. Goodwin, J.S., Drake, K.R., Rogers, C.,
Wright, L., Lippincott-Schwartz, J.,CURBIO 7242_7260Philips, M.R., and Kenworthy, A.K. (2005).
Depalmitoylated Ras traffics to and from the
Golgi complex via a nonvesicular pathway.
J. Cell Biol. 170, 261–272.
4. Rocks, O., Peyker, A., Kahms, M., Verveer, P.J.,
Koerner, C., Lumbierres, M., Kuhlmann, J.,
Waldmann, H., Wittinghofer, A., and
Bastiaens, P.I. (2005). An acylation cycle
regulates localization and activity of
palmitoylated Ras isoforms. Science 307,
1746–1752.
5. Silvius, J.R., Bhagatji, P., Leventis, R., and
Terrone, D. (2006). K-ras4B and prenylated
proteins lacking ‘‘second signals’’ associate
dynamically with cellular membranes. Mol. Biol.
Cell 17, 192–202.
6. Fivaz, M., and Meyer, T. (2005). Reversible
intracellular translocation of KRas but not
HRas in hippocampal neurons regulated
by Ca2+/calmodulin. J. Cell Biol. 170,
429–441.
7. Bivona, T.G., Quatela, S.E., Bodemann, B.O.,
Ahearn, I.O., Soskis, M.J., Mor, A., Miura, J.,
Wiener, H.H., Wright, L., Saba, S.G., et al.
(2006). PKC regulates a farnesyl-electrostatic
switch on K-Ras that promotes its
association with Bcl-XL on mitochondria
and induces apoptosis. Mol. Cell 21,
481–493.
8. Chiu, V.K., Bivona, T., Hach, A., Sajous, J.B.,
Silletti, J., Wiener, H., Johnson, R.L., Cox, A.D.,
and Philips, M.R. (2002). Ras signalling on the
endoplasmic reticulum and the Golgi. Nat. Cell
Biol. 4, 343–350.
9. Daniels, M.A., Teixeiro, E., Gill, J.,
Hausmann, B., Roubaty, D., Holmberg, K.,
Werlen, G., Hollander, G.A., Gascoigne, N.R.,
and Palmer, E. (2006). Thymic selection
threshold defined by compartmentalization
of Ras/MAPK signalling. Nature 444,
724–729.
10. Onken, B., Wiener, H., Philips, M., and
Chang, E.C. (2006). Compartmentalized
signaling of Ras in fission yeast. Proc. Natl.
Acad. Sci. USA 103, 9045–9050.
11. Di Fiore, P.P., and De Camilli, P. (2001).
Endocytosis and signaling. an inseparable
partnership. Cell 106, 1–4.
12. Zoncu, R., Perera, R.M., Balkin, D.M.,
Pirruccello, M., Toomre, D., and De
Camilli, P. (2009). A phosphoinositide switch
controls the maturation and signaling
properties of APPL endosomes. Cell 136,
1110–1121.
13. Lu, A., Tebar, F., Alvarez-Moya, B.,
Lo´pez-Alcala´, C., Calvo, M., Enrich, C.,
Agell, N., Nakamura, T., Matsuda, M., and
Bachs, O. (2009). A clathrin-dependent
pathway leads to KRas signaling on late
endosomes en route to lysosomes. J. Cell Biol.
184, 863–879.
14. Oksvold, M.P., Skarpen, E., Wierod, L.,
Paulsen, R.E., and Huitfeldt, H.S. (2001).
Re-localization of activated EGF receptor and
its signal transducers to multivesicular
compartments downstream of early
endosomes in response to EGF. Eur. J. Cell
Biol. 80, 285–294.
15. Ostenfeld, M.S., Hoyer-Hansen, M.,
Bastholm, L., Fehrenbacher, N., Olsen, O.D.,
Groth-Pedersen, L., Puustinen, P., Kirkegaard-
Sorensen, T., Nylandsted, J., Farkas, T., et al.
(2008). Anti-cancer agent siramesine is
a lysosomotropic detergent that induces
cytoprotective autophagosome accumulation.
Autophagy 4, 487–499.
16. Fehrenbacher, N., Bastholm, L., Kirkegaard-
Sorensen, T., Rafn, B., Bottzauw, T.,
Nielsen, C., Weber, E., Shirasawa, S.,
Kallunki, T., and Jaattela, M. (2008).
Sensitization to the lysosomal cell
death pathway by oncogene-induced
down-regulation of lysosome-associated
membrane proteins 1 and 2. Cancer Res. 68,
6623–6633.
17. Omerovic, J., Hammond, D.E., Clague, M.J.,
and Prior, I.A. (2008). Ras isoform abundance
and signalling in human cancer cell lines.
Oncogene 27, 2754–2762.
Dispatch
R45718. Roy, S., Wyse, B., and Hancock, J.F. (2002).
H-Ras signaling and K-Ras signaling are
differentially dependent on endocytosis. Mol.
Cell. Biol. 22, 5128–5140.
19. Jura, N., Scotto-Lavino, E., Sobczyk, A., and
Bar-Sagi, D. (2006). Differential modification ofGut Microbiology:
Intestinal Neighbou
Microbes inhabiting the gut affect our h
new studies now show that these effec
competitive interactions between the b
B.P. Willing1 and B.B. Finlay1,2,3
Our gastrointestinal tracts teem with
an immensely abundant and diverse
microbial population. That we have
a symbiotic relationship with this
population is evident as resident
bacteria increase our digestive
capabilities, create nutrients that would
otherwise not be present and exclude
harmful pathogens. There is, however,
a growing appreciation for how
intertwined our physiology is with that
of our inhabitants [1]. Gut bacteria
have recently been found to impact
many aspects of human health,
including immune development,
inflammatory bowel diseases, obesity,
diabetes, allergic diseases, enteric
diseases and cancer [2–5]. Now that
studies have revealed a diverse set
of microbial products that can be
detected systemically within the host,
these effects are not so surprising [6].
Each individual’s digestive tract is
home to a conservative estimate of
500–1000 bacterial species, most of
which cannot currently be cultured,
and whose genomes collectively
represent approximately 100 times
the number of genes present in the
human genome [7]. There is large
inter-individual variation in community
composition at the species level;
however, the microbial composition
of all healthy individuals is dominated
by two main phyla, Bacteroidetes
and Firmicutes [8].
Some diseases, such as Crohn’s,
are linked to the disappearance or
appearance of specific members of
these phyla [2], while others, such as
obesity, are linked to a more general
shift in the ratio of Bacteroidetes to
Firmicutes [3]. However, the causes
of these population shifts are notRas proteins by ubiquitination. Mol. Cell 21,
679–687.
20. Galperin, E., and Sorkin, A. (2008). Endosomal
targeting of MEK2 requires RAF, MEK kinase
activity and clathrin-dependent endocytosis.
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apparent, nor are the mechanisms by
which these shifts result in disease or
susceptibility. It has therefore become
apparent that understanding the
mechanisms that govern the bacterial
population and how they exert their
effects on each other and on the host
will be essential to facilitate the
development of strategies to
manipulate the microbiota to promote
health.
Metagenomic and metaproteomic
approaches have made it possible to
broadly explore the biological
processes driving this complex
community. For example, a surprising
proportion of proteins found in the
faeces were identified as ones involved
in innate immune defense, indicating
an extensive effort of the host to
regulate the microbial population [9].
But these methods are highly
dependent on computational analysis
of DNA or protein sequences, and
because of the diversity of the
microbiota, interactions between these
systems are not easily pieced together.
A recent study by Mahowald et al.
[10] begins to unravel the complexity
of the relationships that govern
the community ecology of the
gastrointestinal tract by creating and
characterizing a highly simplified
model gut microbiota. Bacteroides
thetaiotaomicron and Eubacterium
rectale, chosen as representative
organisms of the two main phyla,
Bacteroidetes and Firmicutes,
respectively, were introduced into
‘gnotobiotic’ mice, which initially lack
any gut bacteria. The mice were either
colonized with each bacterium alone
(mono-association) or co-colonized
by both species, and then
transcriptional profiling of bacteria
and host was performed.
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DOI: 10.1016/j.cub.2009.04.045Using this model system, Mahowald
et al. [10] demonstrate a number of
interactions that have previously been
hypothesized but have not been shown
in vivo (Figure 1). Firstly, they show
that these two bacteria change their
behaviour as a result of competition
for nutrients. B. thetaiotaomicron
responds to co-colonization by
increasing its repertoire of
glycan-degrading enzymes and
signaling the host to produce
glycans that it, but not E. rectale, can
utilize. Comparison of the genomes
of B. thetaiotaomicron and other
sequenced Bacteroidetes to those of
E. rectale and other sequenced
Firmicutes revealed that Bacteroidetes
contain a relative surplus of glycan
degrading enzymes. This may suggest
that foraging on host glycans as a result
of competition with Firmicutes may be
a common adaptation used to remain
competitive. Conversely, E. rectale
appears to more effectively access
nutrients in the presence of
B. thetaiotaomicron, as evidenced
by increased expression of a number
of amino acid and peptide transporters.
The results of this study also indicate
there are synergistic interactions
between these two bacteria. It
appears that acetylCoA produced
by B. thetaiotaomicron is utilized by
E. rectale and is subsequently
converted to butyrate. Crossfeeding
between gut bacteria has been
observed before in vitro [11], but this
is the first time that synergistic
actions between bacteria have been
shown to occur in vivo and to impact
on host physiology, as many
expression changes observed in
co-colonized mice have been
reported to be affected by increased
butyrate production [12]. Previous
studies of how the host responds to
single bacterial species have shown
that each species can affect the
expression of hundreds of host genes
[13], and that different commensal
organisms have dramatically different
effects [14]. Important to the
interpretation of host–microbe
interactions, the Mahowald et al.
